For a listing of the top 10 pharmaceutical/biotechnology companies ranked by DTC media breakdown in 2014, please click on the link below: Top 10 Companies Media Breakdown MAN0615

For a listing of the top 20 pharma/biotech companies ranked by DTC spending in 2014, please click on the link below: Top 20 Companies DTC MAN0615

For a listing of the top 20 prescription medicines ranked by DTC expenditure in 2014, please click on the link below: Top 20 Brands DTC MAN0615

For a listing of media type based on DTC expenditure in 2014, please click on the link below: Media Type DTC MAN0615

For a listing of the total DTC expenditure for prescription medicines in 2012, 2013 and 2014, please click on the link below: Total DTC Spend 2012-2014 MAN0615

For a listing of the top 100 biotechnology companies ranked by 2014 R&D, please click on the link below: R&D Top 100 Layout MAN0615

For a listing of the top 100 biotechnology companies ranked by 2014 revenue, please click on the link below: Revenue Top 100 Layout MAN0615

The U.S. biotechnology arena is undergoing a record-breaking M&A cycle for the industry. After generating M&A activity valued at $235 billion during 2014, the U.S. biotech sector produced more than $100 billion in deals during first-quarter 2015.

By John Kamp • Executive Director of the Coalition for Healthcare Communication So, you already know that the 300+ page bill which includes a broad array of amendments related to […]

Changes at the top at Giant Steven Gold has been selected as CEO and Jeffrey Nemy has joined the company as chief financial officer. Gold, who is one of Giant’s […]